Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Sai Life Sciences Ltd. Share Price
Day's Range
Day's Range
Low
₹1,076.10
High
₹1,094.00
Price Summary
| Previous Close | ₹1,089.70 |
|---|---|
| Day's Range | ₹1,076.10 - ₹1,094.00 |
| Open | ₹1,082.40 |
| 52 Week Range | ₹687.05 - ₹1,100.00 |
| Volume | 2,61,854 |
| Market Cap | ₹0.02 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 2,843.05 |
|---|---|
| Market Cap (₹ in Mn) | 0.02 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 69.36 |
| TTM EPS (₹) | 15.70 |
| P/E Ratio | 93.36 |
| Book Value(₹) | 9.74 |
| PAT Margin (%) | 10.03 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 15.53 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 4397.78 | 14186.82 |
| Expenses | N/A | N/A |
| PBT | 716.48 | 1290.05 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 538.51 | 952.31 |
About Sai Life Sciences Ltd.
| Founded | 1999 |
|---|---|
| Managing Director | Krishnam Raju Kanumuri |
| NSE Symbol | SAILIFE |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,40,134.01 | 1,831.30 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,77,883.86 | 6,681.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,47,526.68 | 4,351.60 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,12,696.26 | 7,820.45 | 6,677.50 - 6,677.50 |
| Lupin Ltd. | 1,12,463.67 | 2,460.50 | 1,836.80 - 1,836.80 |
| Cipla Ltd. | 1,10,088.66 | 1,361.00 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,09,072.97 | 1,307.00 | 1,138.50 - 1,138.50 |
| Max Healthcare Institute Ltd. | 98,793.98 | 1,015.10 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 98,063.24 | 2,375.40 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 94,596.06 | 940.10 | 835.50 - 835.50 |
No Records Found
Latest News
Sai Life Sciences informs about disclosure
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with SEBI Circular on the Industry Standards Note on Regulation 30 dated 25 February 2025, Sai Life Sciences has informed that an Order dated 29th April, 2026 was passed by the Joint Commissioner of Commercial Taxes (Appeals), Kalaburagi u/s 107 (11) of the Central Goods and Services Tax Act, 2017 and the Karnataka Goods and Services Tax Act, 2017. The details as required in terms of Regulation 30 read with Schedule III of the Listing Regulations is enclosed as Annexure - I.
The above information is a part of company’s filings submitted to BSE.
Sai Life Sciences informs about disclosure
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with SEBI Circular on the Industry Standards Note on Regulation 30 dated 25 February 2025, Sai Life Sciences has informed that an Order dated 29th April, 2026 was passed by the Joint Commissioner of Commercial Taxes (Appeals), Kalaburagi u/s 107 (11) of the Central Goods and Services Tax Act, 2017 and the Karnataka Goods and Services Tax Act, 2017. The details as required in terms of Regulation 30 read with Schedule III of the Listing Regulations is enclosed as Annexure - I.
The above information is a part of company’s filings submitted to BSE.
Sai Life Sciences informs about updates
Sai Life Sciences informs about analyst meet
Sai Life Sciences informs about allotment of equity shares under ESOP
With reference to intimation dated February 23, 2026, regarding the allotment of equity shares pursuant to the exercise of options under Employees Stock Option Plan 2008 (‘ESOP 2008’) and Management ESOP Plan 2018 (‘MESOP 2018’), Sai Life Sciences has informed that allotment of 10,000 ESOP shares was inadvertently omitted in the previously submitted intimation. The Board of Directors of the Company has approved and allotted 29,007 and 1,10,000 fully paid-up equity shares of Re 1 each upon exercise of options granted under ESOP 2008 and MESOP 2018 respectively vide their Board Meeting held on 22 February 2026. The total number of shares allotted stands revised accordingly. The details required under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 are enclosed as Annexure-A. Further, the details required as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November 2024 are enclosed as Annexure-B.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Sai Life Sciences Ltd. is ₹1,089.70 as of 2026-05-07.
The market capitalisation of Sai Life Sciences Ltd. is ₹23,091.48 as of 2026-05-07.
The 1-year return of Sai Life Sciences Ltd. is 0.00% as of 2026-05-07.
The P/E ratio of Sai Life Sciences Ltd. is 93.36 as of 2026-05-08.
The 52-week high and low of Sai Life Sciences Ltd. are ₹1,100.00 and ₹687.05, respectively, as of 2026-05-07.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
